5 Amgen (AMGN) Issues to Watch in the Earnings Report - Oppenheimer

January 26, 2021 6:24 AM EST Send to a Friend
Oppenheimer analyst Jay Olson reiterated an Outperform rating and $266.00 price target on Amgen (NASDAQ: AMGN) but noted 5 issues ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login